For the Quarter Ending September 2025
North America
• In the USA, the Cetirizine Dihydrochloride Price Index fell by 0.25% quarter-over-quarter, reflecting importer frontloading.
• The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186653.33/MT, CFR Houston market.
• Importers accelerated purchases pushed the Cetirizine Dihydrochloride Spot Price higher amid port congestion and logistics.
• Short-term order flows and policy uncertainty inform the Cetirizine Dihydrochloride Price Forecast indicating modest stability.
• Rising freight and handling charges influenced the Cetirizine Dihydrochloride Production Cost Trend, increasing landed costs.
• Steady end-user consumption combined with strategic restocking shapes the Cetirizine Dihydrochloride Demand Outlook near term.
• Inventory accumulation at ports and warehouses tightened availability, exerting upward pressure on the Price Index.
• Suppliers selectively raised offers while major producers remained operational, limiting downside and reducing volatility significantly.
Why did the price of Cetirizine Dihydrochloride change in September 2025 in North America?
• Pre-emptive importer buying ahead of tariff measures concentrated demand, tightening short-term supply and elevating costs.
• Port congestion and higher freight raised landed costs, prompting suppliers to increase offers for imports.
• Stable pharmaceutical demand and strategic restocking limited inventory declines, supporting modest price resilience through September.
APAC
• In China, the Cetirizine Dihydrochloride Price Index fell by 0.45% quarter-over-quarter, reflecting stable Indian imports.
• The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186116.67/MT, based on reported shipments.
• Cetirizine Dihydrochloride Spot Price movements remained muted as steady imports kept short-term transactional volumes predictable.
• Cetirizine Dihydrochloride Price Forecast projects modest oscillation while the Price Index reflects balanced supply and demand.
• Cetirizine Dihydrochloride Production Cost Trend shows limited upward pressure from freight and input chemical costs.
• Cetirizine Dihydrochloride Demand Outlook remains steady, supported by formulation schedules and seasonal allergy medication requirements.
• Rising inventories after August restocking pressured the Price Index, while export demand provided intermittent support.
• Major producers maintained operations; Cetirizine Dihydrochloride Price Index stability benefited from reliable Indian supplier deliveries.
Why did the price of Cetirizine Dihydrochloride change in September 2025 in APAC?
• Consistent Indian imports prevented shortages, limiting upward pressure despite moderate freight cost increases affecting margins.
• Cautious distributor purchasing and holiday-related inventory adjustments temporarily tightened supply chains and transactional availability conditions.
• Downstream steady demand from formulators sustained volumes, moderating price declines amid cautious market sentiment overall.
Europe
• In Germany, the Cetirizine Dihydrochloride Price Index fell by 0.26% quarter-over-quarter, reflecting port congestion impacts.
• The average Cetirizine Dihydrochloride price for the quarter was approximately USD 186543.33/MT under CFR Hamburg delivery conditions.
• Elevated Cetirizine Dihydrochloride Spot Price reflected shorter stocks and higher freight, tightening the Price Index.
• Near-term Cetirizine Dihydrochloride Price Forecast signals modest upside as importers restock ahead of autumn congestion.
• Rising freight and handling charges influenced the Cetirizine Dihydrochloride Production Cost Trend, pressuring margins for distributors.
• Stable downstream healthcare demand supports the Cetirizine Dihydrochloride Demand Outlook despite procurement and inventory adjustments.
• Inventory drawdowns and early forward buying tightened supply, lifting the Cetirizine Dihydrochloride Price Index regionally.
• Major supplier lead times extended from berth delays and river limits, increasing supply scheduling uncertainty.
Why did the price of Cetirizine Dihydrochloride change in September 2025 in Europe?
• Severe port congestion and berth delays delayed imports, reducing available spot supply and delivery certainty.
• Higher freight surcharges and routing increased landed costs, pressuring margins and elevating short-term procurement prices.
• Importers accelerated restocking amid uncertainty, tightening available inventories while downstream demand remained steady but cautious.
For the Quarter Ending June 2025
North America
• The Price Index for Cetirizine Dihydrochloride in the USA fell from USD 190,180/MT in April to USD 185,200/MT in May, before slightly recovering to USD 186,000/MT in June, reflecting a net Q2 decline of 2.2%.
• In April, a 145% tariff on Chinese imports triggered frontloaded procurement, raising landed costs and tightening supply, which modestly lifted the price index.
• Despite inflation easing in April (CPI rose only 0.2%), demand outlook for Cetirizine Dihydrochloride remained steady due to high inventory buffering by U.S. buyers.
• Product spot price dropped 2.62% in May as pharmaceutical buyers paused procurement amid regulatory changes and tariff recalibrations.
• The introduction of the “Most Favored Nation” pricing policy on May 12 led to uncertainty, delaying purchasing decisions and altering the product price forecast.
• In May, reduced Chinese shipments (-20.8% MoM) and inventory rationalization among importers pressured the production cost trend downward.
• June saw a 0.43% uptick in the price index, driven by anticipatory buying during the U.S.–China trade truce.
• Steady domestic consumption and inflationary cost adjustments in June mildly tightened market availability.
• Forward buying ahead of Q3 placed modest upward pressure on the product spot price, stabilizing the market.
• In July 2025, with inflation easing and post-May bottlenecks clearing, the price index is likely to increase slightly as importer confidence improves.
APAC
• The Price Index for Cetirizine Dihydrochloride in China fell by 5.06% in April, with spot prices dropping to USD 190,090/MT, amid weak overseas procurement and domestic oversupply conditions.
• Domestic factories faced inventory pressure due to a contraction in the manufacturing sector, compounded by the imposition of 145% U.S. tariffs that sharply curtailed exports—affecting the product production cost trend due to inefficient operations.
• In May, the Price Index further declined by 2.65%, reaching USD 185,060/MT, as Chinese suppliers struggled with rising backlogs of unsold material and continued order hesitancy, reflecting a muted product demand outlook.
• Weak new export orders and delayed shipments in May pressured suppliers to adopt aggressive pricing strategies, especially as buyers held off amid uncertainty in trade policy.
• The June Price Index inched up by 0.35% to USD 185,700/MT, attributed to short-term export recovery following a temporary 90-day suspension of U.S. tariffs announced in mid-May.
• The spot price increase in June was supported by advanced overseas orders and rising ocean freight rates, signaling better momentum in the product price forecast.
• June saw a partial rebound in export-oriented production, alleviating some overcapacity issues, although manufacturers remained cautious about future runs, reflecting volatile product production cost trend expectations.
• Product demand outlook improved slightly in June as downstream formulation segments maintained routine procurement and U.S. buyers front-loaded orders ahead of the tariff window.
• For July 2025, prices are likely to remain stable or show mild increases, as cautious overseas buyers resume activity without aggressive restocking due to unclear U.S. trade signals.
• Inventory levels have begun to ease slightly, but the Chinese market remains broadly well-supplied, limiting the scope for a sharp upward revision in the product price forecast.
Europe
• The Cetirizine Dihydrochloride Price Index in Germany declined by 6.5% in April, followed by a 2.64% drop in May, before recovering slightly by 0.40% in June, with the product spot price shifting from USD 190,120/MT in April to USD 185,850/MT in June.
• April’s decline was due to a supply glut from diverted U.S.-bound cargoes, pre-holiday stockpiling, and weak product demand outlook from pharmaceutical sectors.
• Product production cost trend remained stable, but high inventories and rerouted supplies from Asia led to excess availability in April and May.
• May’s price drop was driven by inflationary pressure, cautious buyers, and lingering post-tariff disruptions that complicated procurement cycles.
• Severe port congestion across Hamburg, Antwerp, and Bremerhaven in May delayed replenishment and deterred fresh orders.
• By June, the Price Index increased slightly due to disrupted supply chains, worsened port congestion, and early restocking to hedge against longer lead times.
• June’s product demand outlook remained cautious, with importers buying just enough to manage supply risk without overstocking.
• Rhine River's low water levels limited inland transport, amplifying delivery concerns and adding upward pressure on spot prices.
• For July 2025, prices are likely to increase modestly as consumer sentiment improves, importers regain confidence, and shipping backlogs begin to ease.
• Stabilizing inflation and forward purchases at higher values are expected to strengthen the product price forecast for Q3.
